TNFSF10 and malignant colon neoplasm: High expressions of the DR4 and DR5 receptors, which are the agonistic TRAIL receptors, were reported as the contributor of CSCs’ resistance to TRAIL-mediated effects and the chemo-resistant characteristic observed in colon cancer [152].